International Biotechnology Trust - IBT Share Forecast, Price & News

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.

International Biotechnology Trust Stock Up 0.7 %

Shares of IBT traded up GBX 5 ($0.06) during trading hours on Thursday, reaching GBX 704 ($8.51). The company's stock had a trading volume of 54,343 shares, compared to its average volume of 70,758. The company has a quick ratio of 0.00, a current ratio of 0.00 and a debt-to-equity ratio of 16.90. International Biotechnology Trust has a 1-year low of GBX 563 ($6.80) and a 1-year high of GBX 773.25 ($9.34). The company has a 50 day moving average of GBX 667.28 and a two-hundred day moving average of GBX 648.27. The firm has a market cap of £287.68 million and a price-to-earnings ratio of -7.30.

International Biotechnology Trust Announces Dividend

The business also recently disclosed a dividend, which will be paid on Friday, August 26th. Stockholders of record on Thursday, August 4th will be paid a GBX 15.70 ($0.19) dividend. The ex-dividend date is Thursday, August 4th. This represents a dividend yield of 2.27%. International Biotechnology Trust's dividend payout ratio is currently -0.31%.